title: The immunomodulatory oligodendrocyte.
abstract: Oligodendrocytes, the myelinating glial cells of the central nervous system (CNS), are due to their high specialization and metabolic needs highly vulnerable to various insults. This led to a general view that oligodendrocytes are defenseless victims during brain damage such as occurs in acute and chronic CNS inflammation. However, this view is challenged by increasing evidence that oligodendrocytes are capable of expressing a wide range of immunomodulatory molecules. They express various cytokines and chemokines (e.g. Il-1β, Il17A, CCL2, CXCL10), antigen presenting molecules (MHC class I and II) and co-stimulatory molecules (e.g. CD9, CD81), complement and complement receptor molecules (e.g. C1s, C2 and C3, C1R), complement regulatory molecules (e.g. CD46, CD55, CD59), tetraspanins (e.g. TSPAN2), neuroimmune regulatory proteins (e.g. CD200, CD47) as well as extracellular matrix proteins (e.g. VCAN) and many others. Their potential immunomodulatory properties can, at specific times and locations, influence ongoing immune processes as shown by numerous publications. Therefore, oligodendrocytes are well capable of immunomodulation, especially during the initiation or resolution of immune processes in which subtle signaling might tip the scale. A better understanding of the immunomodulatory oligodendrocyte can help to invent new, innovative therapeutic interventions in various diseases such as Multiple Sclerosis. This article is part of a Special Issue entitled SI: Myelin Evolution.
authors.affiliation: Neurobiology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
authors.forename: Thomas
authors.initials: T
authors.lastname: Zeis
authors.affiliation: Neurobiology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
authors.forename: Lukas
authors.initials: L
authors.lastname: Enz
authors.affiliation: Neurobiology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland. Electronic address: Nicole.Schaeren-Wiemers@unibas.ch.
authors.forename: Nicole
authors.initials: N
authors.lastname: Schaeren-Wiemers
mesh_terms: D000818:Animals; D001921:Brain / Q000276:immunology; D006801:Humans; D015213:Neuroimmunomodulation / Q000502:physiology*; D009836:Oligodendroglia / Q000378:metabolism*
keywords: Chemokine; Cytokine; Immune process; Immunomodulation; Inflammation; Multiple Sclerosis; NIRegs; Oligodendrocyte; Tetraspanins